Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Fibrin degradation products, D-dimer; qualitative or semiquantitative

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85378 refers to the qualitative or semiquantitative testing of fibrin degradation products, specifically focusing on D-dimer. D-dimer testing is a crucial laboratory procedure utilized primarily to assist in ruling out the presence of a thrombus, which is a blood clot that can obstruct blood flow. The significance of D-dimer lies in its negative predictive value; a negative result from this test indicates that there are no elevated levels of fibrin degradation products in the specimen, suggesting that a thrombus is unlikely. Conversely, a positive result signifies an abnormally high concentration of fibrin degradation products, which may suggest the presence of a thrombus. This test is particularly valuable in diagnosing conditions such as deep vein thrombophlebitis, pulmonary embolism, and stroke. Additionally, D-dimer testing is employed to evaluate hypercoagulability, a condition that increases the risk of blood clots, and to assist in diagnosing disseminated intravascular coagulation (DIC). Furthermore, it can be used to monitor the effectiveness of treatment for DIC. It is important to note that while CPT® Code 85378 encompasses qualitative and semiquantitative testing methodologies, it is distinct from CPT® Code 85379, which involves a quantitative assessment providing specific levels of fibrin degradation products. The testing methodology associated with CPT® Code 85378 is less sensitive compared to that of CPT® Code 85380, which is designed for ultrasensitive testing, yielding rapid and highly accurate results due to its enhanced sensitivity.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The D-dimer test, represented by CPT® Code 85378, is indicated for several clinical scenarios where the presence of thrombus or hypercoagulability is suspected. The following conditions warrant the use of this test:

  • Deep Vein Thrombophlebitis - D-dimer testing is utilized to help rule out the presence of blood clots in the deep veins, which can lead to serious complications if not diagnosed and treated promptly.
  • Pulmonary Embolus - The test aids in the diagnosis of pulmonary embolism, a condition where a blood clot travels to the lungs, potentially causing life-threatening consequences.
  • Stroke - D-dimer testing can assist in evaluating the likelihood of a thrombus contributing to a stroke, thereby guiding further diagnostic and therapeutic interventions.
  • Hypercoagulability Evaluation - The test is also employed to assess conditions that predispose patients to an increased risk of blood clot formation, helping to identify underlying causes of hypercoagulability.
  • Disseminated Intravascular Coagulation (DIC) - D-dimer testing is used to help diagnose DIC, a serious condition characterized by widespread clotting and bleeding, and to monitor the effectiveness of treatment for this disorder.

2. Procedure

The procedure for conducting the D-dimer test under CPT® Code 85378 involves several key steps that ensure accurate results. The following outlines the procedural steps:

  • Specimen Collection - A blood sample is collected from the patient, typically via venipuncture. The specimen must be handled with care to avoid contamination and ensure the integrity of the sample for testing.
  • Laboratory Processing - The collected blood sample is processed in a laboratory setting. This may involve centrifugation to separate plasma from blood cells, as the D-dimer test is performed on the plasma component.
  • Testing Methodology - The qualitative or semiquantitative testing for D-dimer is then conducted using specific reagents and methodologies designed to detect the presence of fibrin degradation products. This step may involve the use of immunoassays or other laboratory techniques that can identify D-dimer levels.
  • Result Interpretation - After the testing is completed, the results are interpreted by laboratory personnel. A positive result indicates elevated levels of D-dimer, suggesting the presence of a thrombus, while a negative result indicates no significant elevation, ruling out thrombus presence.
  • Reporting - Finally, the results are documented and reported to the requesting physician or healthcare provider, who will use the information to guide further clinical decision-making.

3. Post-Procedure

Post-procedure care for patients undergoing D-dimer testing is generally minimal, as the test is non-invasive and involves only a blood draw. Patients may be advised to maintain hydration and can typically resume normal activities immediately following the procedure. It is important for healthcare providers to communicate the significance of the test results to the patient, including any necessary follow-up actions based on the outcomes. If the D-dimer test results are positive, further diagnostic imaging or clinical evaluation may be warranted to confirm the presence of a thrombus or to investigate other underlying conditions. In cases where the test is negative, it may provide reassurance regarding the absence of significant thrombotic events.

Short Descr FIBRIN DEGRADE SEMIQUANT
Medium Descr FIBRIN DGRADJ PRODUCTS D-DIMER QUAL/SEMIQUAN
Long Descr Fibrin degradation products, D-dimer; qualitative or semiquantitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
CR Catastrophe/disaster related
GW Service not related to the hospice patient's terminal condition
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
X1 Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care
Date
Action
Notes
2011-01-01 Changed Short description changed.
2003-01-01 Changed Code description changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"